[New drugs. Topoisomerase inhibitors].
Gutzler
F
F
Med. Klinik und Poliklinik, Universität, Heidelberg.
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D000077146:Irinotecan; D013329:Structure-Activity Relationship; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D019772:Topotecan; D002166:Camptothecin